Global cosmetics research, development and manufacturing (ODM) corporation COSMAX said it has obtained certification of conformity with medical device manufacturing and quality control standards (GMP).
Medical device GMP (Good Manufacturing Practice) is a management standard to ensure quality and safety across the medical device manufacturing process, and can only be acquired by meeting strict facility, hygiene and validation systems. With this certification, COSMAX has laid a full-scale foundation for entering the dermatology-focused hospital and clinic market.
Accordingly, COSMAX plans to accelerate development of "MD cream" products targeted at dermatology and hospital specialist markets. MD cream corresponds to an adhesive transparent wound dressing classified as a class 2 medical device.
An adhesive transparent wound dressing is a transparent adhesive covering used to protect wounds with low exudate; it is a category of medical device approved for purposes such as wound covering and creating a moist environment to protect the skin.
COSMAX plans to marshal its accumulated dermal research, bio-material development, formulation technology capabilities and know-how to develop various MD cream products and expand its business portfolio to cover lawful approvals, validation procedures and manufacturing.
Kang Seung-hyun, unit head of COSMAX R&I Center, said this GMP certification is an achievement that opened a new chapter as medical devices beyond cosmetics, and added that based on this they will continue convergence research that breaks down the boundaries between skin science and bio technology to contribute to practical patient care.
This year COSMAX launched a bio-materials development organization, "COSMAX BF (Bio Foundry)," and is building a technical consortium for the industrial use of the skin microbiome. Furthermore, through joint research with Harvard in the field of skin microbiome, it is researching and developing innovative technologies for skin care, and plans to use this as a basis to secure differentiated competitiveness in the global market.